Allogene Therapeutics
ALLO
ALLO
161 hedge funds and large institutions have $586M invested in Allogene Therapeutics in 2024 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 54 increasing their positions, 46 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less funds holding
Funds holding: 170 → 161 (-9)
28% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 32
Holders
161
Holding in Top 10
2
Calls
$1.28M
Puts
$260K
Top Buyers
| 1 | +$30.2M | |
| 2 | +$17.2M | |
| 3 | +$12.8M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$8.07M |
| 5 |
VPC
Vestal Point Capital
New York
|
+$6.03M |
Top Sellers
| 1 | -$9.13M | |
| 2 | -$7.71M | |
| 3 | -$7.68M | |
| 4 |
Morgan Stanley
New York
|
-$4.93M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.2M |